ID: ALA4783169

Max Phase: Preclinical

Molecular Formula: C17H16F3N3O3

Molecular Weight: 367.33

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C(=O)O)nc(N2CCC(Oc3ccccc3C(F)(F)F)C2)n1

Standard InChI:  InChI=1S/C17H16F3N3O3/c1-10-8-13(15(24)25)22-16(21-10)23-7-6-11(9-23)26-14-5-3-2-4-12(14)17(18,19)20/h2-5,8,11H,6-7,9H2,1H3,(H,24,25)

Standard InChI Key:  ABEOJZVPYJLYGA-UHFFFAOYSA-N

Associated Targets(Human)

Plasma retinol-binding protein 718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Transthyretin 2847 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.33Molecular Weight (Monoisotopic): 367.1144AlogP: 3.16#Rotatable Bonds: 4
Polar Surface Area: 75.55Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.55CX Basic pKa: 5.87CX LogP: 1.96CX LogD: 0.55
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.89Np Likeness Score: -1.18

References

1. Cioffi CL,Muthuraman P,Raja A,Varadi A,Racz B,Petrukhin K.  (2020)  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.,  63  (19): [PMID:32878437] [10.1021/acs.jmedchem.0c00996]

Source